JHOP - December 2015 Vol 5, No 4

Opioid-induced constipation (OIC) is a common distressing symptom in patients with cancer who are taking opioids.
The use of oral chemotherapy has increased dramatically for many types of cancer. This shift from infusion-based therapy introduces new challenges to ensuring safe prescribing, dispensing, administration, and monitoring.
There have been a multitude of advances in the treatment of metastatic melanoma in the past decade, including approval of newer targeted therapies that often are better tolerated than previously used chemotherapy and immunotherapies.
The current treatment landscape for patients with high-risk localized prostate cancer is predominantly confined to a combination of androgen-deprivation therapy (ADT) plus radiotherapy, which has been shown to improve survival over radiotherapy alone.

Results 1 - 4 of 4